Market Place
Sourcing Support
Microbix Presents Novel HSV Test Control at EMMD
07 Oct 2024 //
GLOBENEWSWIRE
Microbix Achieves Essential EU Regulatory Accreditations
03 Oct 2024 //
GLOBENEWSWIRE
Microbix Presenting at Muskoka Capital Conference
25 Sep 2024 //
GLOBENEWSWIRE
Microbix Reports Continued Strong Results for Q3 Fiscal 2024
14 Aug 2024 //
GLOBENEWSWIRE
Microbix Schedules Release of Results for Q3 Fiscal 2024
07 Aug 2024 //
GLOBENEWSWIRE
Microbix Presents HCV FLOQSwab® Format Test Control at ADLM
25 Jul 2024 //
GLOBENEWSWIRE
Microbix Hosts Minister Nina Tangri To Open Capacity Expansions
17 Jun 2024 //
GLOBENEWSWIRE
Microbix Advances Test-Ingredient Manufacturing Capabilities
04 Jun 2024 //
GLOBENEWSWIRE
Microbix Reports Strong Results for Q2 Fiscal 2024
15 May 2024 //
GLOBENEWSWIRE
Microbix Schedules Release of Results for Q2 Fiscal 2024
08 May 2024 //
GLOBENEWSWIRE
Microbix Collaborator Introduces New Lab Accreditation Program
25 Apr 2024 //
GLOBENEWSWIRE
Microbix Presenting at the 2024 Bloom Burton Conference
11 Apr 2024 //
GLOBENEWSWIRE
Microbix Announces Annual and Special Meeting Voting Results
01 Apr 2024 //
GLOBENEWSWIRE
Microbix™s Clot-Buster Drug Project Advances
14 Mar 2024 //
GLOBENEWSWIRE
Microbix Unveils Test Controls for Head and Neck Cancer
11 Mar 2024 //
GLOBENEWSWIRE
Microbix Announces Issuance of Stock Options
26 Feb 2024 //
GLOBENEWSWIRE
Microbix Reports Record Results for Q1 Fiscal 2024
14 Feb 2024 //
GLOBENEWSWIRE
Microbix Schedules Release of Results for Q1 Fiscal 2024
07 Feb 2024 //
GLOBENEWSWIRE
Microbix Unveils Test Control for Gastric Ulcer Disease Pathogen
06 Feb 2024 //
GLOBENEWSWIRE
Microbix Achieves Further QAPs Sales Record
03 Jan 2024 //
GLOBENEWSWIRE
Microbix Reports Results for Q4 & Full-Year Fiscal 2023
21 Dec 2023 //
GLOBENEWSWIRE
Microbix & Seegene USA Jointly Enhancing Lab Test Accuracy
14 Dec 2023 //
GLOBENEWSWIRE
Microbix & BioGX Collaborate on real-time PCR Assays & Controls
07 Dec 2023 //
GLOBENEWSWIRE
Microbix Announces Initiation of Normal Course Issuer Bid
06 Dec 2023 //
GLOBENEWSWIRE
Microbix Presenting at Florida Capital Event Conference
17 Nov 2023 //
GLOBENEWSWIRE
Microbix Clot-Buster Drug Fully-Funded For Return to U.S. Market
16 Nov 2023 //
GLOBENEWSWIRE
Microbix & Ulisse Biomed Collaborate on HPV Controls & Assays
10 Nov 2023 //
GLOBENEWSWIRE
Microbix QAPs Supporting HPV Testing in Ireland
27 Oct 2023 //
GLOBENEWSWIRE
Microbix Presenting at Muskoka Capital Conference
29 Sep 2023 //
GLOBENEWSWIRE
Microbix Achieves New QAPs Sales Record
27 Sep 2023 //
GLOBENEWSWIRE
Microbix Reports Results for Q3 Fiscal 2023
10 Aug 2023 //
GLOBENEWSWIRE
Microbix Presents Results of STI Test Controls at AACC
24 Jul 2023 //
GLOBENEWSWIRE
Microbix QAPs Supporting HPV Testing Across The Netherlands
05 Jul 2023 //
GLOBENEWSWIRE
Microbix & Labquality Create Novel Testing Accreditation Program
20 Jun 2023 //
GLOBENEWSWIRE
Microbix Presents Results of STI Test Controls at ASM Microbe
13 Jun 2023 //
GLOBENEWSWIRE
Microbix Announces Extension of Warrant Expiry Date
18 May 2023 //
GLOBENEWSWIRE
Microbix Secures Funded Drug Commercialization Agreement
16 May 2023 //
GLOBENEWSWIRE
Microbix Reports Results for Q2 Fiscal 2023
11 May 2023 //
GLOBENEWSWIRE
Microbix Presenting at the 2023 Bloom Burton Conference
20 Apr 2023 //
GLOBENEWSWIRE
Microbix Announces Annual and Special Meeting Voting Results
30 Mar 2023 //
GLOBENEWSWIRE
Governments of Ontario and Canada Invest in Microbix
20 Mar 2023 //
GLOBENEWSWIRE
Microbix Supporting Australian Point-of-Care Testing Program
01 Mar 2023 //
GLOBENEWSWIRE
Microbix Announces Issuance of Stock Options
27 Feb 2023 //
GLOBENEWSWIRE
Microbix Reports Results for Q1 Fiscal 2023 Sales of $2.5 million
09 Feb 2023 //
GLOBENEWSWIRE
Microbix Presenting Results of Collaboration with Health PEI
06 Feb 2023 //
GLOBENEWSWIRE
Microbix Launches QAP to Support “Monkeypox†Testing
30 Jan 2023 //
GLOBENEWSWIRE
Microbix Reports Record Sales for Fiscal 2022
22 Dec 2022 //
GLOBENEWSWIRE
Microbix Presenting Test-Workflow Validation Results at EMMD
06 Oct 2022 //
GLOBENEWSWIRE
Microbix Announces Initiation of Normal Course Issuer Bid
28 Sep 2022 //
GLOBENEWSWIRE
Microbix Presenting STI Multiplex Test Controls at AACC
26 Jul 2022 //
GLOBENEWSWIRE
Microbix Presenting Test Validation Methods at AACC
03 Jun 2022 //
GLOBENEWSWIRE
Microbix Reports Record Results for Q2 Fiscal 2022
12 May 2022 //
GLOBENEWSWIRE
Microbix Presenting at the 2022 Bloom Burton Conference
28 Apr 2022 //
GLOBENEWSWIRE
Microbix Presenting Respiratory Virus Controls Data at Two Events
19 Apr 2022 //
GLOBENEWSWIRE
Microbix Presenting HPV Product Results at EUROGIN
08 Apr 2022 //
GLOBENEWSWIRE
Microbix Invests to Further Scale Its Business
29 Mar 2022 //
GLOBENEWSWIRE
Microbix Announces Issuance of Stock Options
24 Feb 2022 //
GLOBENEWSWIRE
Microbix Receives $4.7 Million Order for Viral Transport Medium
24 Dec 2021 //
GLOBENEWSWIRE
